• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

免疫吸附和血浆置换在抗中性粒细胞胞浆抗体或抗肾小球基底膜清除动力学方面具有可比性。

Immunoadsorption and Plasma Exchange are Comparable in Anti-Neutrophil Cytoplasmic Antibodies or Anti-Glomerular Basement Membrane Removal Kinetics.

作者信息

Sallee Marion, Resseguier Noémie, Crepin Thomas, Bertin Daniel, Bertrand Dominique, Bobot Mickaël, Krummel Thierry, Maillard Nicolas, Moussi-Frances Julie, Pelletier Marion, Poullin Pascale, Rafat Cédric, Robert Thomas, Terrier Benjamin, Rostaing Lionel, Faguer Stanislas, Jourde-Chiche Noémie

机构信息

AP-HM, Hôpital de la Conception, Centre de Néphrologie et Transplantation Rénale, Marseille, France.

Aix-Marseille Univ, C2VN, INSERM, INRAE, Marseille, France.

出版信息

Kidney Int Rep. 2024 Jun 27;9(9):2767-2773. doi: 10.1016/j.ekir.2024.06.031. eCollection 2024 Sep.

DOI:10.1016/j.ekir.2024.06.031
PMID:39291196
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11403088/
Abstract

INTRODUCTION

Apheresis allows the fast removal of autoantibodies in anti-glomerular basement membrane (anti-GBM) disease, and in severe antineutrophil cytoplasmic antibodies (ANCA)-associated vasculitis. The CINEVAS study tested whether immunoadsorption (IA) allowed a faster removal of ANCA and/or anti-GBM antibodies than plasma exchanges (PEx).

METHODS

CINEVAS was a prospective multicenter study comparing IA to PEx in consecutive patients with ANCA and/or anti-GBM vasculitides. The primary objective was the reduction rate in autoantibody titers between the beginning of the first and the end of the seventh apheresis session. Secondary objectives were number of sessions needed to obtain desired reduction rates; reduction rates of total Ig levels; tolerance of sessions; and patients' outcome.

RESULTS

The results of 38 patients (16 treated with IA and 22 with PEx), and 43 autoantibodies, were analyzed. There was no difference in the reduction rates in autoantibody titers between IA and PEx over 7 sessions (respectively 98% vs. 96%,  = 0.39). The numbers of sessions needed to obtain undetectable autoantibodies, or 50%, 75%, or 90% reductions, did not differ between techniques. Greater reduction rates of autoantibodies were observed when plasma was separated by filtration compared to centrifugation, with IA and PEx. IA allowed a greater reduction in total IgG levels, and better preservation of total IgA and IgM levels than PEx. PEx sessions required higher volumes of plasma, IA sessions higher volumes of citrate; IA sessions were longer.

CONCLUSIONS

IA and PEx were comparable in ANCA or anti-GBM removal kinetics, despite a faster reduction in total IgG with IA.

摘要

引言

单采术可快速清除抗肾小球基底膜(anti-GBM)病以及重症抗中性粒细胞胞浆抗体(ANCA)相关性血管炎中的自身抗体。CINEVAS研究旨在测试免疫吸附(IA)是否比血浆置换(PEx)能更快清除ANCA和/或抗GBM抗体。

方法

CINEVAS是一项前瞻性多中心研究,比较IA与PEx对连续的ANCA和/或抗GBM血管炎患者的治疗效果。主要目标是第一次单采术开始至第七次单采术结束期间自身抗体滴度的降低率。次要目标包括达到期望降低率所需的单采术次数;总免疫球蛋白水平的降低率;单采术的耐受性;以及患者的预后。

结果

分析了38例患者(16例接受IA治疗,22例接受PEx治疗)及43种自身抗体的结果。在7次单采术中,IA和PEx之间自身抗体滴度的降低率无差异(分别为98%对96%,P = 0.39)。两种技术在使自身抗体不可检测或降低50%、75%或90%所需的单采术次数上没有差异。与离心法分离血浆相比,采用过滤法分离血浆时,IA和PEx均观察到自身抗体有更大的降低率。与PEx相比,IA能使总IgG水平有更大程度的降低,同时能更好地保留总IgA和IgM水平。PEx单采术需要更高体积的血浆,IA单采术需要更高体积的枸橼酸盐;IA单采术时间更长。

结论

尽管IA能更快降低总IgG水平,但在清除ANCA或抗GBM的动力学方面,IA和PEx具有可比性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/497c/11403088/76a17283d389/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/497c/11403088/46149bbcfc65/ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/497c/11403088/76a17283d389/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/497c/11403088/46149bbcfc65/ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/497c/11403088/76a17283d389/gr1.jpg

相似文献

1
Immunoadsorption and Plasma Exchange are Comparable in Anti-Neutrophil Cytoplasmic Antibodies or Anti-Glomerular Basement Membrane Removal Kinetics.免疫吸附和血浆置换在抗中性粒细胞胞浆抗体或抗肾小球基底膜清除动力学方面具有可比性。
Kidney Int Rep. 2024 Jun 27;9(9):2767-2773. doi: 10.1016/j.ekir.2024.06.031. eCollection 2024 Sep.
2
Influence of variable domain glycosylation on anti-neutrophil cytoplasmic autoantibodies and anti-glomerular basement membrane autoantibodies.可变域糖基化对中性粒细胞胞浆自身抗体和抗肾小球基底膜自身抗体的影响。
BMC Immunol. 2012 Mar 9;13:10. doi: 10.1186/1471-2172-13-10.
3
Double positivity for antineutrophil cytoplasmic antibody (ANCA) and anti-glomerular basement membrane antibody could predict end-stage renal disease in ANCA-associated vasculitis: a monocentric pilot study.抗中性粒细胞胞浆抗体(ANCA)和抗肾小球基底膜抗体双重阳性可预测抗中性粒细胞胞浆抗体相关性血管炎的终末期肾病:一项单中心的初步研究。
Clin Rheumatol. 2020 Mar;39(3):831-840. doi: 10.1007/s10067-019-04854-1. Epub 2019 Dec 4.
4
Apheresis to treat systemic vasculitis.用血细胞分离术治疗系统性血管炎。
Joint Bone Spine. 2018 Mar;85(2):177-183. doi: 10.1016/j.jbspin.2017.06.001. Epub 2017 Jun 7.
5
[Comparison of plasma exchange (PEX) vs. double filtration plasmapheresis (DFPP) with or without steroid administration in a case of MPO-ANCA-positive immune complex type crescentic glomerulonephritis].[血浆置换(PEX)与双重滤过血浆置换(DFPP)在MPO-ANCA阳性免疫复合物型新月体性肾小球肾炎病例中应用或不应用类固醇的比较]
Nihon Jinzo Gakkai Shi. 2000 Jul;42(5):374-80.
6
Clinical characteristics and outcome of double-seropositive patients with anti-glomerular basement membrane antibodies and anti-neutrophil cytoplasmic antibodies.抗肾小球基底膜抗体和抗中性粒细胞胞质抗体双重阳性患者的临床特征和转归。
Int Immunopharmacol. 2024 Sep 10;138:112607. doi: 10.1016/j.intimp.2024.112607. Epub 2024 Jul 8.
7
Staphylococcal protein A immunoadsorption for Goodpasture's syndrome in four Chinese patients.葡萄球菌蛋白A免疫吸附疗法治疗4例中国患者的Goodpasture综合征
J Nephrol. 2006 May-Jun;19(3):312-7.
8
Efficacy of protein A immunoadsorption and therapeutic plasma exchange in ANCA-associated vasculitis with severe renal involvement: a retrospective study.蛋白 A 免疫吸附和治疗性血浆置换在伴有严重肾损害的抗中性粒细胞胞浆抗体相关性血管炎中的疗效:一项回顾性研究。
Ann Med. 2023 Dec;55(1):2230875. doi: 10.1080/07853890.2023.2230875.
9
More selective removal of myeloperoxidase-anti-neutrophil cytoplasmic antibody from the circulation of patients with vasculitides using a novel double-filtration plasmapheresis therapy.使用一种新型双重过滤血浆置换疗法,更有选择性地从血管炎患者的循环系统中清除髓过氧化物酶抗中性粒细胞胞浆抗体。
Ther Apher Dial. 2013 Feb;17(1):93-8. doi: 10.1111/j.1744-9987.2012.01107.x. Epub 2012 Nov 20.
10
A case of anti-neutrophil cytoplasmic antibody-associated vasculitis with anti-glomerular basement membrane antibodies that was successfully treated with mizoribine as a safe and effective remission maintenance therapy with prednisolone and plasma exchange.一例抗中性粒细胞胞浆抗体相关性血管炎合并抗肾小球基底膜抗体,经米佐米星联合泼尼松和血浆置换成功治疗,作为一种安全有效的缓解维持治疗。
CEN Case Rep. 2020 Feb;9(1):42-47. doi: 10.1007/s13730-019-00423-2. Epub 2019 Oct 14.

本文引用的文献

1
Efficacy of protein A immunoadsorption and therapeutic plasma exchange in ANCA-associated vasculitis with severe renal involvement: a retrospective study.蛋白 A 免疫吸附和治疗性血浆置换在伴有严重肾损害的抗中性粒细胞胞浆抗体相关性血管炎中的疗效:一项回顾性研究。
Ann Med. 2023 Dec;55(1):2230875. doi: 10.1080/07853890.2023.2230875.
2
EULAR recommendations for the management of ANCA-associated vasculitis: 2022 update.EULAR 推荐的抗中性粒细胞胞浆抗体相关性血管炎治疗:2022 年更新。
Ann Rheum Dis. 2024 Jan 2;83(1):30-47. doi: 10.1136/ard-2022-223764.
3
Anti-glomerular Basement Membrane Glomerulonephritis: A Study in Real Life.
抗肾小球基底膜肾小球肾炎:一项现实生活中的研究。
Front Med (Lausanne). 2022 Jul 5;9:889185. doi: 10.3389/fmed.2022.889185. eCollection 2022.
4
Executive summary of the KDIGO 2021 Guideline for the Management of Glomerular Diseases.KDIGO 2021肾小球疾病管理指南执行摘要。
Kidney Int. 2021 Oct;100(4):753-779. doi: 10.1016/j.kint.2021.05.015.
5
Update to the ASFA guidelines on the use of therapeutic apheresis in ANCA-associated vasculitis.更新 ASFA 指南:关于在抗中性粒细胞胞浆抗体相关性血管炎中使用治疗性血液净化的指南。
J Clin Apher. 2020 Sep;35(5):493-499. doi: 10.1002/jca.21820. Epub 2020 Aug 7.
6
Plasma Exchange and Glucocorticoids in Severe ANCA-Associated Vasculitis.血浆置换联合糖皮质激素治疗重症 ANCA 相关性血管炎。
N Engl J Med. 2020 Feb 13;382(7):622-631. doi: 10.1056/NEJMoa1803537.
7
Prognostic Factors in Anti-glomerular Basement Membrane Disease: A Multicenter Study of 119 Patients.抗肾小球基底膜病的预后因素:119 例患者的多中心研究。
Front Immunol. 2019 Jul 18;10:1665. doi: 10.3389/fimmu.2019.01665. eCollection 2019.
8
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice - Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue.临床实践中治疗性血液成分单采术的使用指南——美国血液成分单采学会写作委员会基于证据的方法:第八期特刊
J Clin Apher. 2019 Jun;34(3):171-354. doi: 10.1002/jca.21705.
9
Patients double-seropositive for ANCA and anti-GBM antibodies have varied renal survival, frequency of relapse, and outcomes compared to single-seropositive patients.与单阳性患者相比,同时出现抗中性粒细胞胞浆抗体(ANCA)和抗肾小球基底膜(GBM)抗体双阳性的患者具有不同的肾脏存活率、复发频率和结局。
Kidney Int. 2017 Sep;92(3):693-702. doi: 10.1016/j.kint.2017.03.014. Epub 2017 May 12.
10
Membrane versus centrifuge-based therapeutic plasma exchange: a randomized prospective crossover study.基于膜式与离心式的治疗性血浆置换:一项随机前瞻性交叉研究。
Int Urol Nephrol. 2016 Jan;48(1):133-8. doi: 10.1007/s11255-015-1137-3. Epub 2015 Nov 3.